Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2016-01-19911,2016,Dabanovic 2016 Vojnosanit Pregl,690,"oral treatment with dutasteride in the dosage regimen of 0.5 mg/day VERSUS oral treatment with finasteride in the dosage regimen of 5 mg/day IN Specific disease- benign prostatic hyperplasia; Age- 41 to 64 years, >=65 years; Gender- Male; Country- Montenegro.",26964381,"Specific disease- benign prostatic hyperplasia; Age- 41 to 64 years, >=65 years; Gender- Male; Country- Montenegro.",oral treatment with dutasteride in the dosage regimen of 0.5 mg/day,Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia--The Markov model based on data from Montenegro.,oral treatment with finasteride in the dosage regimen of 5 mg/day,NE
2006-01-12900,2006,Jankovic 2006 Exp Clin Cardiol,230,Low molecular weight heparin enoxaparin VERSUS Unfractionated heparin IN Patients aged 60-70 years with acute deep venous thrombosis (inpatients),18651046,Patients aged 60-70 years with acute deep venous thrombosis (inpatients),Low molecular weight heparin enoxaparin,Cost and utility of a low-molecular-weight heparin and unfractionated heparin for treatment of deep venous thrombosis in a Balkan country: A model analysis.,Unfractionated heparin,NE
2006-01-12900,2006,Jankovic 2006 Exp Clin Cardiol,98,Low molecular weight heparin enoxaparin VERSUS Unfractionated heparin IN Patients aged 60-70 years with acute deep venous thrombosis (outpatients),18651046,Patients aged 60-70 years with acute deep venous thrombosis (outpatients),Low molecular weight heparin enoxaparin,Cost and utility of a low-molecular-weight heparin and unfractionated heparin for treatment of deep venous thrombosis in a Balkan country: A model analysis.,Unfractionated heparin,NE
1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
